Variants of GBA1 known to be associated with PD development include p.E326K, p.T369M, p.N370S and p.L444P, which decrease the activity of glucocerebrosidase, the enzyme encoded by GBA1, and consequently reduce the ability to degrade alpha-synuclein in lysosomes [46]. This evidence concerns the gene SNCA and Parkinson disease.